Why BioNTech Shares Are Trading Higher Today

BioNTech SE - ADR BNTX shares are trading higher by 6% at $225 in sympathy with the overall market as it rebounds from last week's weakness following a shift in the Fed's policy. The company's COVID-19 vaccine was also approved for the 12-15 age group in New Zealand.

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19.

The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies.

Market News and Data brought to you by Benzinga APIs
Posted In: Long IdeasMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!